Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004858890 | SCV005498334 | uncertain significance | not specified | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.88G>T (p.G30C) alteration is located in exon 2 (coding exon 2) of the SCGN gene. This alteration results from a G to T substitution at nucleotide position 88, causing the glycine (G) at amino acid position 30 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |